The somatotrophic system in patients with dilated cardiomyopathy: Relation of insulin-like growth factor-1 and its alterations during growth hormone therapy to cardiac function

Clinical Endocrinology

Volumn 53, Issue 1, 2000, Pages 61-68

  Osterziel, Karl Josef ^a,b   Ranke, Michael B ^a,b   Strohm, Oliver ^a,b   Dietz, Rainer ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART DILATATION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART SIZE; HEART STROKE VOLUME; HORMONE SUBSTITUTION; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; CARDIOMYOPATHY, DILATED; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0033837524     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01029.x     Document Type: Article

References (35)

1. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
2. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
3. Insulin-like growth factors and their binding proteins
4. Radioimmunoassays for IGFs and IGFBPs
5. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency
6. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy
7. Noninvasive evaluation of global left ventricular function with use of cine nuclear magnetic resonance
8. Variability in the quantitation of circulating growth hormone using commercial immunoassays
9. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat
10. The epidemiology of heart failure
11. Idiopathic dilated cardiomyopathy
12. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease
13. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
14. Growth hormone in the treatment of dilated cardiomyopathy
15. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy
16. Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy
17. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
18. A placebo-contolled study of growth hormone in patients with congestive heart failure
19. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
20. Quantitative angiocardiography. I. The normal left ventricle in man
21. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading
22. Left ventricular volumes using cine-MRI: Validation by catherization ventriculography
23. Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis
24. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
25. Treatment of end-stage cardiac failure with growth hormone
26. Role of nitric oxide in the cardiovascular effect of recombinant human growth hormone in patients with dilated cardiomyopathy
27. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
28. Left ventricular volumes measured by MR imaging
29. 2+ handling and enhance cardiac performance
30. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure
31. Nutritional regulation of the insulin-like growth factors
32. Increased myocardial contractility following growth hormone administration in normal man
33. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood
34. Derangements of the somatotropic hormone axis in chronic renal failure
35. Haemodynamic effects of growth hormone in congestive heart failure